Paid Clinical Trials in Corpus Christi, TX
As of September 2026, 65 paid clinical trials are recruiting in Corpus Christi, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Corpus Christi offers studies at sites including Driscoll Children's Hospital for conditions such as Obesity, Overweight, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Corpus Christi
Trials by drug in Corpus Christi
Filter results
Newly added in Corpus Christi
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
61 clinical trials
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
North American Comfilcon A Clinical Study
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
Top Research Study Locations in Corpus Christi
Researchers run research studies in Corpus Christi, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Driscoll Children's Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 29 |
| South Texas Clinical Research | Heart Failure, Obesity, Obesity or Overweight | 4 |
| Arthritis Care of Texas | Cutaneous Lupus Erythematosus (CLE), Sjögren´s Disease, Systemic Lupus Erythematosus (SLE) | 4 |
| Institute of Precision Pain Medicine | Chronic Leg Pain, Chronic Low-back Pain, Chronic Pain | 3 |
| Pinnacle Clinical Research - Corpus Christi | Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Osvaldo A. Brusco MD | Cardiovascular Risk, Obesity, Overweight | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Arthritis & Osteoporosis Center of Coastal Bend | Tophaceous Gout | 1 |
| Arthritis Care of Texas - Corpus Christi | Systemic Lupus Erythematosus (SLE) | 1 |
| Brusco, Corpus Christi, TX | Hypothyroidism | 1 |
| CHRISTUS Spohn Cancer Center | Breast Cancer | 1 |
| CHRISTUS Spohn Hospital Corpus Christi-Shoreline | Emergency Department Patient, QTc Intervals Changes | 1 |
| Corpus Christi Women's Center | Diagnosis, Endometriosis | 1 |
| Driscoll Children's Hosptial | Pneumococcal Disease | 1 |
| Drs. McIntyre, Garza, Avila and Jurica, Optometrists | Ametropia, Astigmatism, Presbyopia | 1 |
| Drs. Mcintyre Garza Avila & Jurica | Presbyopia | 1 |
| GSK Investigational Site | Chickenpox | 1 |
| Lumos Pharma Investigational Site | Growth Hormone Deficiency (GHD) | 1 |
| Osvaldo A Brusco MD PA | Diabetes Mellitus, Type 2, Obesity, Overweight | 1 |
| Pinnacle Clinical Research | Metabolic Dysfunction-associated Steatohepatitis | 1 |
| Private Practice - Dr. Osvaldo A. Brusco | Obesity, Overweight | 1 |
| Saratoga Surgical Center | Lumbar Spinal Stenosis | 1 |
| Spinecare | Lumbar Spinal Stenosis | 1 |
| Texas Ortho Ctr of Excellence | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Corpus Christi (2026)
Recruiting trials in Corpus Christi grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (15 active studies)
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · Phase 2 · National Cancer Institute (NCI)
Diabetes & metabolic (15 active studies)
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
Neurology & pain (3 active studies)
- Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control · Boston Scientific Corporation
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain · Phase 3 · Saol Therapeutics Inc
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Cardiovascular (1 active study)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Common conditions studied in Corpus Christi
- Obesity (5 active studies)
- Overweight (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Diabetes Mellitus, Type 2 (2 active studies)
- Ganglioneuroblastoma, Nodular (2 active studies)
Leading research sponsors in Corpus Christi
- Children's Oncology Group
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Novo Nordisk A/S
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Corpus Christi?
There are approximately 65 recruiting clinical trials in Corpus Christi, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Corpus Christi pay participants?
Most recruiting trials in Corpus Christi compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Corpus Christi?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Corpus Christi?
The most common conditions under active study in Corpus Christi include Obesity (5), Overweight (4), Acute Myeloid Leukemia (3), B Acute Lymphoblastic Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Corpus Christi?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Corpus Christi on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Corpus Christi?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Corpus Christi?
Recruiting research sites in Corpus Christi include Driscoll Children's Hospital, South Texas Clinical Research, Arthritis Care of Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Corpus Christi right now?
The largest active categories in Corpus Christi are Cancer & tumors (15), Diabetes & metabolic (15), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.